Jump to navigation Jump to search

WikiDoc Resources for Leukostasis


Most recent articles on Leukostasis

Most cited articles on Leukostasis

Review articles on Leukostasis

Articles on Leukostasis in N Eng J Med, Lancet, BMJ


Powerpoint slides on Leukostasis

Images of Leukostasis

Photos of Leukostasis

Podcasts & MP3s on Leukostasis

Videos on Leukostasis

Evidence Based Medicine

Cochrane Collaboration on Leukostasis

Bandolier on Leukostasis

TRIP on Leukostasis

Clinical Trials

Ongoing Trials on Leukostasis at Clinical Trials.gov

Trial results on Leukostasis

Clinical Trials on Leukostasis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Leukostasis

NICE Guidance on Leukostasis


FDA on Leukostasis

CDC on Leukostasis


Books on Leukostasis


Leukostasis in the news

Be alerted to news on Leukostasis

News trends on Leukostasis


Blogs on Leukostasis


Definitions of Leukostasis

Patient Resources / Community

Patient resources on Leukostasis

Discussion groups on Leukostasis

Patient Handouts on Leukostasis

Directions to Hospitals Treating Leukostasis

Risk calculators and risk factors for Leukostasis

Healthcare Provider Resources

Symptoms of Leukostasis

Causes & Risk Factors for Leukostasis

Diagnostic studies for Leukostasis

Treatment of Leukostasis

Continuing Medical Education (CME)

CME Programs on Leukostasis


Leukostasis en Espanol

Leukostasis en Francais


Leukostasis in the Marketplace

Patents on Leukostasis

Experimental / Informatics

List of terms related to Leukostasis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Leukostasis (aka symptomatic hyperleukocytosis)[1] is a white blood cell count above 100,000/μL. It is characterized by abnormal intravascular leukocyte aggregation and clumping. It is most often seen in leukemia patients. The brain and lungs are the two most commonly affected organs. Occluded microcirculation causes local hypoxemia and hemorrage manifesting as headache, blurred vision, transient ischemic attacks, cerebrovascular accidents and dyspnea. It is an acute syndrome requiring aggressive cytoreductive modalities including chemotherapy and/or leukapheresis to both reduce the number of circulating leukocytes and to break apart any aggregates that have already formed. It is different from leukemic infiltration which is a neoplastic process where leukemic cells invade organs.[2]


  1. Schiffer, Charles, MD. "Hyperleukocytosis and Leukostasis". UpToDate. Retrieved 25 May 2011.
  2. "Leukostasis". Medical Subject Headings, 2009–2009-02-13. 1995-06-01.